"Leishmaniasis, Visceral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Visceral".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Visceral".
This graph shows the total number of publications written about "Leishmaniasis, Visceral" by people in Harvard Catalyst Profiles by year, and whether "Leishmaniasis, Visceral" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 5 | 0 | 5 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 5 | 0 | 5 |
| 2007 | 3 | 0 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 1 | 5 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 5 | 2 | 7 |
| 2019 | 7 | 0 | 7 |
| 2020 | 3 | 0 | 3 |
| 2021 | 9 | 0 | 9 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Leishmaniasis, Visceral" by people in Profiles.
-
Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani. PLoS One. 2023; 18(1):e0270722.
-
Genetic diversity and population structure of Phlebotomus argentipes: Vector of Leishmania donovani in Sri Lanka. PLoS One. 2021; 16(9):e0256819.
-
IFN?R1 deficiency presenting with visceral leishmaniasis and Mycobacterium Avium infections mimicking HLH. Pediatr Allergy Immunol. 2022 01; 33(1):e13653.
-
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India. PLoS Negl Trop Dis. 2021 08; 15(8):e0009598.
-
Inequalities of visceral leishmaniasis case-fatality in Brazil: A multilevel modeling considering space, time, individual and contextual factors. PLoS Negl Trop Dis. 2021 07; 15(7):e0009567.
-
Human visceral leishmaniasis in Central-Western Brazil: Spatial patterns and its correlation with socioeconomic aspects, environmental indices and canine infection. Acta Trop. 2021 Sep; 221:105965.
-
Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis. J Immunol Res. 2021; 2021:5568077.
-
Jagged-Notch-mediated divergence of immune cell crosstalk maintains the anti-inflammatory response in visceral leishmaniasis. J Cell Sci. 2021 03 04; 134(5).
-
A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis. Biomed Res Int. 2021; 2021:8845826.
-
Colonization and genetic diversification processes of Leishmania infantum in the Americas. Commun Biol. 2021 01 29; 4(1):139.